Medical Weight Loss Education Materials
US$ 25.88
glp-1 receptor agonists blindness risk π Optometrists are warning drugs may pose these types of rare risks π β¬οΈ Details in comments Ocular Effects of GLP-1 Receptor
Description
10.1016/j.molmet.2022.101533
Diabetes Care (2008) 31:S26977
Liraglutide was administered over a 5-week period, revealing a significant increase in gastric retention at 1-h
From steatosis to cirrhosis: the role of obesity in the progression of liver disease
JAMA (2019) 321:1466
Why Are GLP-1 and Peptide Therapies Becoming Popular
